% Finance cost -0.92 -0.82 -0.10 12.2% Income tax expenses -0.94 -2.36 1.42 -60.2% Net income for period 10.49 18.78 -8.29 -44.1% Earnings per share (THB) 0.03 0.06 -0.03 2.8% YTD 2017 Financial Position
. However, EBITDA declined by 5.8% yoy to THB 135 million due to higher administrative expenses and higher share of net losses from investments by the equity method. The Company reported net loss of THB 55
million for 850 million ordinary shares at THB 0.158 per share. Business Segment Performance In 1Q18, total revenue was THB 1,698 million, a 12.5% increase on last year. Total revenue and EBITDA breakdown
) on 3 April 2018, following the performance of the company and its subsidiaries the dividend payment has been approved for the year 2017 at Baht 1.25 per share amounting to Baht 1,872,876,000 or 59% of
Distribution of Newly Issued Shares and Share Warrants by Issuer
’ demand are being met at all times Operational excellence which mean assets reliability, lower costs and maintain high operating rates Working capital management through efficiency improvement like for
-time incurred of approximately Baht 12 million. In addition, the opening of the new Medical Excellence Center and the expansion of the subsidiary’s laboratories have driven the cost of service, expertise
Our Policies Strategic Plan Annual Report Stakeholders in the Capital Market The Foundation of the SEC Toward International Excellence International Relations Contact Us Complaint/Whistleblower Holiday